Oncoscience AG: Clinical Trials

4 trials sponsored by Oncoscience AG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Phase 21Completed 1

Follow Oncoscience AG: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nimotuzumab in Adults With Pancreatic Cancer
Nimotuzumab - Pancreatic Cancer, Advanced or Metastatic
Phase 2 / Phase 3CompletedOncoscience AG1882007-09-012015-10-15
Nimotuzumab in Adults With Glioblastoma Multiforma
nimotuzumab - Adults With Glioblastoma Multiforma
Phase 3CompletedOncoscience AG1502007-08-012012-12-03
Nimotuzumab in Children With Intrinsic Pontine Glioma
nimotuzumab - Diffuse Instrinsic Ponitine Glioma
CompletedOncoscience AG412006-04-012013-03-29
Nimotuzumab in Children With HGG
High Grade Glioma
CompletedOncoscience AG452004-06-012007-11-21

Conditions studied

Astrocytoma (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Neoplasm Metastasis (1)  ·  Pancreatic Neoplasms (1)

Interventions

nimotuzumab (3)

Countries

Germany (4)

Top investigators

Udo Bode, Prof. MD (2)  ·  Dirk Strumberg, MD (1)  ·  Manfred Westphal, Prof. MD (1)

Results publications

PMID 28961832